Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00625417 · ClinicalTrials.gov registry record · NA
Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT00625417 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 102 participants.
The verdict
NCT00625417, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as optical spectroscopy, may help learn the extent of disease and allow doctors to plan better treatment. PURPOSE: This phase I trial is studying optical spectroscopy to see how well it works in evaluating tumor margins in patients who have undergone surgery for breast cancer.
Interventions
- PROCEDURE therapeutic conventional surgery
- PROCEDURE histopathologic examination
- PROCEDURE breast biopsy
- PROCEDURE light-scattering spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2006-08 |
| Est. Completion | 2021-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00625417
The ClinicalTrials.gov registry entry for NCT00625417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which therapeutic conventional surgery is the first listed.
NCT00625417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00625417 about?
NCT00625417 is a clinical study titled "Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors". RATIONALE: Diagnostic procedures, such as optical spectroscopy, may help learn the extent of disease and allow doctors to plan better treatment. PURPOSE: This phase I trial is studying optical spectroscopy to see how well it works in evaluating tumor margins in patients who have undergone surgery f...
What is the current status of trial NCT00625417?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2006-08. Estimated completion is 2021-12.
What interventions are being tested in trial NCT00625417?
The interventions under investigation include: therapeutic conventional surgery (PROCEDURE), histopathologic examination (PROCEDURE), breast biopsy (PROCEDURE), light-scattering spectroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00625417?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.